Covered recipient · General Payments record
ADDISON DI ZHANG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,021.33
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.14 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $90.71 | 5 |
| Exact Sciences Corporation | $39.88 | 2 |
| ABBVIE INC. | $35.43 | 2 |
| Lilly USA, LLC | $30.56 | 2 |
| Amgen Inc. | $28.10 | 2 |
| Acerta Pharma LLC | $18.31 | 1 |
| GlaxoSmithKline, LLC. | $16.47 | 1 |
| Galderma Laboratories, L.P. | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.74 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106394145 | CMS |
| ABBVIE INC. | $19.69 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106394147 | CMS |
| Amgen Inc. | $14.69 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111746832 | CMS |
| Amgen Inc. | $13.41 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422408 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.31 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105900266 | CMS |
| Exact Sciences Corporation | $19.59 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114958584 | CMS |
| Exact Sciences Corporation | $20.29 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114958588 | CMS |
| Galderma Laboratories, L.P. | $15.68 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145337469 | CMS |
| GlaxoSmithKline, LLC. | $16.47 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116413547 | CMS |
| Lilly USA, LLC | $17.13 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136009405 | CMS |
| Lilly USA, LLC | $13.43 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136011889 | CMS |
| Novo Nordisk Inc | $16.38 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621744 | CMS |
| Novo Nordisk Inc | $15.74 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097383050 | CMS |
| Novo Nordisk Inc | $14.10 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097626557 | CMS |
| Novo Nordisk Inc | $23.64 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096931697 | CMS |
| Novo Nordisk Inc | $20.85 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096619454 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.